• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    More On APO.V

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Acasti Pharma Inc. (APO.V)

    -TSXV
    0.60 Down 0.01(1.64%) Mar 27, 10:26AM EDT
    Add to Portfolio
    Prev Close:0.61
    Open:0.60
    Bid:0.59
    Ask:0.61
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:0.60 - 0.60
    52wk Range:0.41 - 1.35
    Volume:1,570
    Avg Vol (3m):28,695
    Market Cap:63.76M
    P/E (ttm):N/A
    EPS (ttm):-0.02
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):2.73
    P/S (ttm):221.67
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Feb-15) :-0.06
    Quarterly EPS Est (Feb-15) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acasti Pharma Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of therapies for abnormalities in blood lipids, and the treatment and prevention of various cardiometabolic disorders in Canada and the... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback